Study identifier:D3565L00002
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
A study to evaluate the efficacy and safety of rosuvastatin in the long-term treatment of hypercholesterolaemic subjects with coronary heart disease as measured by intravascular ultrasonography
Hypercholesteremia
Phase 4
No
Rosuvastatin, HMG CoA inhibitor
All
214
Interventional
20 Years - 75 Years
Allocation: Non-randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Treatment
Verified 01 Aug 2011 by AstraZeneca Pharmaceuticals
AstraZeneca Pharmaceuticals
Shionogi Co.Ltd
No locations available
Arms | Assigned Interventions |
---|